Thyrotropin suppression for papillary thyroid cancer: a physician survey study

M Papaleontiou, DW Chen, M Banerjee… - Thyroid, 2021 - liebertpub.com
Background: Current guidelines recommend against thyrotropin (TSH) suppression in low-
risk differentiated thyroid cancer patients; however, physician practices remain …
被引用次数：29 相关文章

Thyrotropin Suppression for Papillary Thyroid Cancer: A Physician Survey Study.

M Papaleontiou, DW Chen, M Banerjee… - …, 2021 - search.ebscohost.com
Background: Current guidelines recommend against thyrotropin (TSH) suppression in low-
risk differentiated thyroid cancer patients; however, physician practices remain …
[HTML] nih.gov

[HTML][HTML] Thyrotropin Suppression for Papillary Thyroid Cancer: A Physician Survey Study

M Papaleontiou, DW Chen, M Banerjee… - Thyroid, 2021 - ncbi.nlm.nih.gov
Background: Current guidelines recommend against thyrotropin (TSH) suppression in low-
risk differentiated thyroid cancer patients; however, physician practices remain …

Thyrotropin Suppression for Papillary Thyroid Cancer: A Physician Survey Study

M Papaleontiou, DW Chen… - … : official journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background: Current guidelines recommend against thyrotropin (TSH) suppression in low-
risk differentiated thyroid cancer patients; however, physician practices remain …

Thyrotropin Suppression for Papillary Thyroid Cancer: A Physician Survey Study.

M Papaleontiou, DW Chen, M Banerjee… - … : Official Journal of the …, 2021 - europepmc.org
Background: Current guidelines recommend against thyrotropin (TSH) suppression in low-
risk differentiated thyroid cancer patients; however, physician practices remain …